After adjusting for a priori defined confounders (age at diagnosis, sex, tumour location, pTNM stage, differentiation grade, MMR status, and adjuvant therapy status), only GLUT1 and PTEN remained significant predictors of CRC‐specific or overall survival, respectively (Table 3). This evidence concerns the gene SLC2A1 and neoplasm.